Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children
- 31 December 1994
- Vol. 12 (2) , 139-141
- https://doi.org/10.1016/0264-410x(94)90051-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Immune response to split-product influenza vaccine in preterm and full-term young childrenVaccine, 1992
- Immunization of High-Risk Infants Younger Than 18 Months of Age with Split-Product Influenza VaccinePediatrics, 1991
- Acute Respiratory Disease Associated with Influenza Epidemics in Houston, 1981-1983The Journal of Infectious Diseases, 1987
- Children hospitalized with influenza B infectionThe Pediatric Infectious Disease Journal, 1987
- Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79Journal of Clinical Microbiology, 1983
- Ether treatment of type B influenza virus antigen for the hemagglutination inhibition testJournal of Clinical Microbiology, 1981
- Influenza in children. Relationship to other respiratory agentsPublished by American Medical Association (AMA) ,1980
- DISQUISITIONS ON ORIGINAL ANTIGENIC SINThe Journal of Experimental Medicine, 1966